A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study’ (Int J Surg 2023; 109:1299

A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study’ (Int J Surg 2023; 109:1299–310)

Published:2023-05-09 Issue:8 Volume:109 Page:2529-2530
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Huo Teh-Ia¹²³^ORCID,Ho Shu-Yein²⁴,Liao Jia-I⁵²

Affiliation:

1. Department of Medical Research

2. School of Medicine

3. Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan

4. Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan

5. Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference6 articles.

1. Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study;Deng;Int J Surg,2023

2. Albumin–bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma;Ho;Eur J Surg Onco,2019

3. Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg;Lee;Am J Cancer Res,2021

4. Prognosis of hepatocellular carcinoma: assessment of eleven staging systems;Liu;J Hepatol,2016

5. A new tumor burden score and albumin–bilirubin grade-based prognostic model for hepatocellular carcinoma;Ho;Cancers,2022